Aurora Cannabis Shares Jump On Q1 FY25 Earnings, Global Medical Marijuana Yields Record Revenue Of $343M
Portfolio Pulse from Nina Zdinjak
Aurora Cannabis Inc. (NASDAQ:ACB) reported a strong Q1 FY25 with a 12% revenue increase to CA$83.44 million, driven by growth in global medical cannabis and plant propagation. The company achieved positive net income and free cash flow, and its shares rose 9.39% in pre-market trading. Aurora's partnership with Cogent International Manufacturing Ltd. and expansion in key markets like Germany and Australia are expected to support continued growth.
August 07, 2024 | 12:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aurora Cannabis reported a 12% increase in Q1 FY25 revenue, driven by growth in global medical cannabis and plant propagation. The company achieved positive net income and free cash flow, and its shares rose 9.39% in pre-market trading.
The strong financial performance, including revenue growth, positive net income, and free cash flow, is likely to boost investor confidence and drive the stock price higher in the short term. The 9.39% pre-market increase indicates positive market reaction.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100